Advisors Asset Management’s Trueblue TBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07K Sell
154
-61
-28% -$340 ﹤0.01% 1392
2026
Q1
$841 Sell
215
-34
-14% -$151 ﹤0.01% 1439
2025
Q4
$1.13K Sell
249
-61
-20% -$313 ﹤0.01% 1428
2025
Q3
$1.9K Sell
310
-21
-6% -$133 ﹤0.01% 1428
2025
Q2
$2.15K Buy
331
+153
+86% +$824 ﹤0.01% 1440
2025
Q1
$945 Buy
178
+57
+47% +$389 ﹤0.01% 1476
2024
Q4
$1.02K Buy
121
+57
+89% +$440 ﹤0.01% 1460
2024
Q3
$505 Buy
+64
New +$576 ﹤0.01% 1451

Other funds holding TBI

Advisors Asset Management's TBI Position: Q2 2026 in Review

Advisors Asset Management reduced its Trueblue (TBI) stake by 28% in Q2 2026, selling an estimated $340 and leaving 154 shares worth $1.07K. The position accounts for ﹤0.01% of the portfolio, ranked #1392.

Advisors Asset Management first reported a position in TBI in Q3 2024 and has held it in 8 quarters since. The position peaked at $2.15K in Q2 2025. 113 funds tracked by Wall St. Rank hold TBI as of Q2 2026.

  • Advisors Asset Management held 154 shares of Trueblue worth $1.07K as of Q2 2026.
  • Advisors Asset Management sold 61 Trueblue shares in Q2 2026, an estimated $340.
  • Trueblue made up ﹤0.01% of Advisors Asset Management's portfolio in Q2 2026, its #1392 holding.
  • Advisors Asset Management first reported a position in Trueblue in Q3 2024 and has held it in 8 quarters since.
  • Advisors Asset Management's Trueblue position peaked at $2.15K in Q2 2025.
  • 113 funds tracked by Wall St. Rank held Trueblue as of Q2 2026.

Based on Advisors Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.